Guru Ownership Trend
Guru Analysis for Rhythm Pharmaceuticals, Inc. (RYTM)
Rhythm Pharmaceuticals, Inc. (RYTM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $104.37 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $29.84 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 24.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Rhythm Pharmaceuticals, Inc. (RYTM)
Major holders include Steven Cohen ($73.65 M), Renaissance Technologies (RenTech) ($22.44 M), Cliff Asness ($5.16 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.19 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $29.84 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited RYTM. The total reported sell value was $8.17 M.
Yes, 1 managers opened new positions in RYTM, and 1 increased their existing holdings. The total reported buy value was $38.01 M.